Maxim Artyomov

Maxim Artyomov is an Alumni Endowed Professor and Professor of Pathology and Immunology at Washington University School of Medicine, with affiliations to the Institute of Clinical and Translational Sciences (ICTS), Bursky Center for Human Immunology & Immunotherapy Programs (CHiiPs), and Siteman Cancer Center. His research spans Systems Immunology, Immunometabolism, and Cancer Immunology, focusing on integrating epigenetic, transcriptional, and metabolic regulation in immune cells.

• 2018 promoted to Associate Professor with Tenure
• 2017 awarded LEAP Inventor Challenge
• 2018 Unanue Prize for Innovative Research in Immunology

Key research contributions include:

• Discovery of itaconate's anti-inflammatory role (2016)
• Metabolic reprogramming in macrophage polarization (2015)
• TREM2's function in microglial metabolic fitness (2017)
• Development of CORESH gene signature search engine (2025)

His high-throughput omics pipelines enable cross-disciplinary analysis of immune responses in tuberculosis, Alzheimer's, and cancer. Notable collaborations include work with Schreiber's lab on immune checkpoint therapy (2018) and ITMO University on systems biology workshops (2017-2018).

Awards and grants include the Unanue Prize (2018), LEAP Inventor Challenge (2017), and R01 grant from NIAID (2017). He mentors PhD/MSTP students and co-organizes international systems biology workshops.